𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I study of intravenous 4-hydroxyanisole

✍ Scribed by Rustin, Gordon J.; Stratford, Michael R.; Lamont, Alan; Bleehen, Norman; Philip, Philip A.; Howells, Nest; Watfa, Rodeina R.; Slack, John A.

Book ID
121884379
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
382 KB
Volume
28
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase-I study of intravenous modified li
Phase-I study of intravenous modified lipid A
✍ Gerald J. Vosika; Charles Barr; Dennis Gilbertson πŸ“‚ Article πŸ“… 1984 πŸ› Springer-Verlag 🌐 English βš– 607 KB

Endotoxin and the lipid-A portion of the molecule have a variety of biological effects, including the induction of necrosis and regression of malignancy. To date extensive clinical trials of endotoxin as a potential therapeutic agent have been shunned due to the toxicity of the material. Several lip

Phase I study with 4β€² -deoxydoxorubicin
Phase I study with 4β€² -deoxydoxorubicin
✍ Laura Ferrari; Anna Rossi; Cristina Brambilla; Valeria Bonfante; Fabrizio Villan πŸ“‚ Article πŸ“… 1984 πŸ› Springer US 🌐 English βš– 630 KB

4'-Deoxydoxorubicin (dxDx), a new doxorubicin analogue, was administered intravenously on a 3-week schedule to 73 patients affected by advanced malignant neoplasms. Sixty-five patients, treated with eight dose levels ranging from 10 to 45 mg/m 2 , were evaluable. The dose-limiting toxicity was myelo